Yes even the marketing claims on these are provisoed around that.
As accurate as PCR in our clinical trials, as accurate when results are interpreted properly. And so forth. And “as accurate” seems to come about by comparison to the lowest bar of PCR tests.
There’s far too many variables at home with regards who and how for them to actually be as good as a PCR applied in a clinical setting.
And a lot of the excitement on these, and why they were developed is as a faster and potentially more cost effective test for those clinical settings. A much more reliable home test is kinda a bonus. Shouldn’t compare clinical use to home use in either case. It’s: at the hospital as good as PCR but faster. At home, all the stumbling blocks inherent to that, much better than an antigen home kits.
The small number of approved tests, and I think there are some clinical ones too, is likely because they’re very new. They just hit the timing necessary to get studies out. When I was checking into them it seems a bunch promising ones didn’t get emergency approval because they stumbled with Delta and now Omicron. Not enough data, and looked like they had trouble detecting it.
Costs are interesting.
At home PCR tests seem to run about $110-150, and they take much longer cause you have to mail them off.
Even the quite expensive Cue tests are only about $75 each. It’s the fact that they’re only sold in multipacks and by subscription, and the hub costing $250 that makes them very expensive to get into.
The detect kids are $50 a test. Either is cheaper than home PCR test kits. But a home rapid test is like $10-12
I can’t tell you what any of these costs in a proper healthcare context. But from what gather it’s a similar ranking.
With either company the intent doesn’t seem to be to replace the rapid tests for lots of regular testing. It seems to be to provide a better and more cost effect approach for organizations.
Either so they can do cost effective, more reliable testing onsite. Or for those places that regularly send a test to employees. A lot of employers have been sending employees a rapid test per week this whole time. Now they can potentially send one of these a month.
For clinical settings. From what I understand the idea is that there are both costs, and logistical delays that these can eliminate. We keep getting longer waits on PCR results whenever we have a new “wave”, crunches in available appointments. And a lot of places are collecting up the tests and shipping them to offsite labs and what have.
Running that grade of tests, in an hour, onsite. Could clear a lot of that up, and lower costs overall. The tests themselves are cheaper, if only a bit. But a lot of the logistics gets cleared away. It’s also got implications for mobile and random testing along the same lines. You can do more of it, more easily and cheaper than PCR. But get better information than antigen.
I suspect this is part of why the Cue tests are so expensive. They’ll sell it to you. But it’s not really meant to sit on your bathroom counter, where you can use it in a pinch.